Growth Control and Genomic Stability
生长控制和基因组稳定性
基本信息
- 批准号:7944583
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-14 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAdenovirusesAffectAmino AcidsApoptoticAwardBRCA1 geneBiologyBudgetsCancer Center Support GrantCell AgingCell CycleCell Cycle RegulationCell ProliferationCell SizeCellsChlamydomonasChromatinChromatin ModelingChromosomesDNA DamageDNA Double Strand BreakDevelopmentDirect CostsFunctional disorderGene Expression RegulationGeneticGenome StabilityGenomic InstabilityGenomicsGoalsGrantGrowthHomeostasisHumanLaboratoriesLibrariesLightMaintenanceMalignant NeoplasmsMediatingMembraneMethodsMitosisModelingModificationMutationNuclear PoreNuclear ReceptorsOncogenicOncolyticOrganismPathway interactionsPeer ReviewPlayProcessProtein p53ProteinsPublicationsRegulationRegulation of Cell SizeResearchResectedRoleSignal PathwaySignal TransductionSmall Interfering RNASomatic CellStem cellsStressSystemTP53 geneTelomeraseTherapeuticTrans-ActivatorsTranscriptional RegulationTranslatingTumor Suppressor ProteinsUbiquitinationViralVirusYeastsbiological adaptation to stresscancer cellcancer typecell typechromatin modificationcrosslinkgenome-widehomologous recombinationhuman FRAP1 proteinin vivointerestmembermouse modelmutantneoplastic cellnovel therapeuticsnucleasepreventprogramsreconstitutionrepairedresponsetelomere
项目摘要
The scientific goals and central themes of the Growth Control and Genomic Stability Program are to
understand mechanisms of proliferation and cell size regulation, transcriptional regulation of oncogenic
signaling pathways, DMA damage response, maintenance of genomic integrity and telomere function, and
how these processes are disrupted in cancer cells.
The program includes ten members from six different laboratories: Beverly Emerson (transcriptional
regulation by the p53 tumor suppressor), Martin Hetzer (nuclear pore assembly mechanisms and cancer),
Katherine Jones (Wnt/p-catenin signaling pathways and transcriptional regulation), Jan Karlseder (telomere
function and dysregulation in cancer cells), Vicki Lundblad (telomere regulation in yeast), Clodagh O'Shea
(oncolytic adenoviruses and adenovirus-targeted proliferation pathways), James Umen (RB pathway*"
regulation and cell size in Chlamydomonas), Geoffrey Wahl (p53 stress response pathway), Lei Wang
(unnatural amino acid incorporation in tumor cells and stem cells), and Matthew Weitzman (host cell DNA
damage response systems abrogated by viruses).
The total amount of peer-reviewed support (direct costs) for the last budget year was $3,325,741. Of this
amount, $920,040 was awarded by the NCI.
The total number of publications by members of this program in the last grant period (2004-2008) was 132.
Of the total publications, 3% were intraprogrammatic and 11% were interprogrammatic (see Section 8 for
explanation of how the program reorganization affects these numbers).
生长控制和基因组稳定计划的科学目标和中心主题是
了解细胞增殖和大小调节、癌基因转录调控的机制
信号通路,DMA损伤反应,维持基因组完整性和端粒功能,以及
这些过程是如何在癌细胞中被破坏的。
该计划包括来自六个不同实验室的十名成员:Beverly Emerson(转录
P53肿瘤抑制因子的调控),Martin Hetzer(核孔组装机制与癌症),
凯瑟琳·琼斯(Wnt/p-catenin信号通路和转录调控),Jan Karlseder(端粒
癌细胞的功能和失调),Vicki Lundblad(酵母中的端粒调节),Clovagh O‘Shea
(溶瘤腺病毒和腺病毒靶向的增殖途径),James Umen(Rb途径*)
衣藻的调节和细胞大小),杰弗里·瓦尔(P53应激反应通路),王磊
(肿瘤细胞和干细胞中非天然氨基酸掺入)和Matthew Weitzman(宿主细胞DNA
被病毒废除的损害反应系统)。
上一预算年度经同行审查的支助(直接费用)总额为3 325 741美元。这一点
NCI判给了920,040美元。
在上一次赠款期间(2004-2008年),该方案成员发表的出版物总数为132份。
在所有出版物中,3%是方案内出版物,11%是方案间出版物(见第8节
解释计划重组如何影响这些数字)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Geoffrey Myles Wahl其他文献
Geoffrey Myles Wahl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Geoffrey Myles Wahl', 18)}}的其他基金
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity
结合单细胞方法和发育视角来发现干细胞控制回路以及癌症异质性的细胞和分子基础
- 批准号:
9115083 - 财政年份:2015
- 资助金额:
$ 2.57万 - 项目类别:
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity
结合单细胞方法和发育视角来发现干细胞控制回路以及癌症异质性的细胞和分子基础
- 批准号:
10219974 - 财政年份:2015
- 资助金额:
$ 2.57万 - 项目类别:
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity
结合单细胞方法和发育视角来发现干细胞控制回路以及癌症异质性的细胞和分子基础
- 批准号:
8955700 - 财政年份:2015
- 资助金额:
$ 2.57万 - 项目类别:
High throughput screen for inhibitors of the mdm2/mdmx interaction
mdm2/mdmx 相互作用抑制剂的高通量筛选
- 批准号:
7844780 - 财政年份:2010
- 资助金额:
$ 2.57万 - 项目类别:
High throughput screen for inhibitors of the mdm2/mdmx interaction
mdm2/mdmx 相互作用抑制剂的高通量筛选
- 批准号:
8018614 - 财政年份:2010
- 资助金额:
$ 2.57万 - 项目类别:
Mouse Models to Elucidate p53 Regulatory Mechanisms
阐明 p53 调节机制的小鼠模型
- 批准号:
6881681 - 财政年份:2003
- 资助金额:
$ 2.57万 - 项目类别:
Mouse Models to Elucidate p53 Regulatory Mechanisms
阐明 p53 调节机制的小鼠模型
- 批准号:
6736855 - 财政年份:2003
- 资助金额:
$ 2.57万 - 项目类别:
Mouse Models to Elucidate p53 Regulatory Mechanisms
阐明 p53 调节机制的小鼠模型
- 批准号:
7214636 - 财政年份:2003
- 资助金额:
$ 2.57万 - 项目类别:
Mouse Models to Elucidate p53 Regulatory Mechanisms
阐明 p53 调节机制的小鼠模型
- 批准号:
7034664 - 财政年份:2003
- 资助金额:
$ 2.57万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 2.57万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 2.57万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 2.57万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 2.57万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 2.57万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 2.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)